Stock Track | Icon PLC Soars 5.98% as Analysts Maintain Buy Ratings and Optimistic Outlooks

Stock Track

02-20

Shares of Icon PLC, a global provider of outsourced drug and device development and commercialization services, surged 5.98% in Thursday's pre-market trading session. The stock's rally comes after two analysts reiterated their Buy ratings on the company, citing positive outlooks.

Truist Financial analyst Jailendra Singh maintained a Buy rating on Icon, highlighting the company's strong financial performance and growth prospects. Singh expressed optimism about Icon's ability to capitalize on the increasing demand for outsourced clinical research services.

Additionally, TD Cowen analyst Charles Rhyee maintained a Buy rating on Icon, with a price target of $254.00. Rhyee's report emphasized Icon's diversified service offerings and robust pipeline as key drivers for future growth.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1173135100"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1173135100\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1173135100?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-20 22:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1173135100","market":"us","top_or_hot":-1,"title":"Stock Track | Icon PLC Soars 5.98% as Analysts Maintain Buy Ratings and Optimistic Outlooks","media":"Stock Track","content":"<p>Shares of Icon PLC, a global provider of outsourced drug and device development and commercialization services, surged 5.98% in Thursday's pre-market trading session. The stock's rally comes after two analysts reiterated their Buy ratings on the company, citing positive outlooks.</p>\n\n<p>Truist Financial analyst Jailendra Singh maintained a Buy rating on Icon, highlighting the company's strong financial performance and growth prospects. Singh expressed optimism about Icon's ability to capitalize on the increasing demand for outsourced clinical research services.</p>\n\n<p>Additionally, TD Cowen analyst Charles Rhyee maintained a Buy rating on Icon, with a price target of $254.00. Rhyee's report emphasized Icon's diversified service offerings and robust pipeline as key drivers for future growth.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Icon PLC Soars 5.98% as Analysts Maintain Buy Ratings and Optimistic Outlooks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Icon PLC Soars 5.98% as Analysts Maintain Buy Ratings and Optimistic Outlooks\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-20 22:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Icon PLC, a global provider of outsourced drug and device development and commercialization services, surged 5.98% in Thursday's pre-market trading session. The stock's rally comes after two analysts reiterated their Buy ratings on the company, citing positive outlooks.</p>\n\n<p>Truist Financial analyst Jailendra Singh maintained a Buy rating on Icon, highlighting the company's strong financial performance and growth prospects. Singh expressed optimism about Icon's ability to capitalize on the increasing demand for outsourced clinical research services.</p>\n\n<p>Additionally, TD Cowen analyst Charles Rhyee maintained a Buy rating on Icon, with a price target of $254.00. Rhyee's report emphasized Icon's diversified service offerings and robust pipeline as key drivers for future growth.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ICLR","symbol_name":"ICON plc","start_time":0,"source_url":"","article_id":"1173135100","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1173135100","pubTimestamp":1740062356,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Icon PLC, a global provider of outsourced drug and device development and commercialization services, surged 5.98% in Thursday's pre-market trading session. The stock's rally comes after two analysts reiterated their Buy ratings on the company, citing positive outlooks.Truist Financial analyst Jailendra Singh maintained a Buy rating on Icon, highlighting the company's strong financial performance and growth prospects. Singh expressed optimism about Icon's ability to capitalize on the i","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ICLR":"ICON plc"},"translate_title":"分析师维持买入评级和乐观前景，股票赛道Icon PLC飙升5.98%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ICLR":1},"content_text":"Shares of Icon PLC, a global provider of outsourced drug and device development and commercialization services, surged 5.98% in Thursday's pre-market trading session. The stock's rally comes after two analysts reiterated their Buy ratings on the company, citing positive outlooks.\nTruist Financial analyst Jailendra Singh maintained a Buy rating on Icon, highlighting the company's strong financial performance and growth prospects. Singh expressed optimism about Icon's ability to capitalize on the increasing demand for outsourced clinical research services.\nAdditionally, TD Cowen analyst Charles Rhyee maintained a Buy rating on Icon, with a price target of $254.00. Rhyee's report emphasized Icon's diversified service offerings and robust pipeline as key drivers for future growth.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1}}}